| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 10,938,000 | 12,697,000 | 13,113,000 | 13,001,000 | | Cost of Revenue | 1,984,000 | 2,708,000 | 3,178,000 | 3,149,000 | | | Gross Profit | 8,954,000 | 9,989,000 | 9,935,000 | 9,852,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,806,000 | 8,732,000 | 7,847,000 | 7,946,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 430,000 | 454,000 | 456,000 | 452,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 718,000 | 803,000 | 1,632,000 | 1,454,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,000 | 17,000 | (13,000) | 14,000 | | Earnings Before Interest And Taxes | 731,000 | 820,000 | 1,619,000 | 1,468,000 | | Interest Expense | 82,000 | 100,000 | 104,000 | 104,000 | | Income Before Tax | 649,000 | 720,000 | 1,515,000 | 1,364,000 | | Income Tax Expense | 248,000 | 466,000 | 545,000 | 491,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 401,000 | 254,000 | 970,000 | 873,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 401,000 | 254,000 | 970,000 | 873,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $401,000 | $254,000 | $970,000 | $873,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
